The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Park Place Capital Corp

Park Place Capital Corp lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,023 shares of the medical device company’s stock after selling 137 shares during the period. Park Place Capital Corp’s holdings in Cooper Companies were worth $94,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in COO. American Century Companies Inc. grew its holdings in shares of Cooper Companies by 3.9% in the 2nd quarter. American Century Companies Inc. now owns 42,911 shares of the medical device company’s stock worth $3,746,000 after acquiring an additional 1,600 shares during the period. Mutual of America Capital Management LLC purchased a new stake in Cooper Companies during the second quarter worth $2,186,000. Pacer Advisors Inc. grew its holdings in Cooper Companies by 28.5% in the second quarter. Pacer Advisors Inc. now owns 17,465 shares of the medical device company’s stock valued at $1,525,000 after purchasing an additional 3,870 shares during the last quarter. Sei Investments Co. increased its position in shares of Cooper Companies by 15.6% in the second quarter. Sei Investments Co. now owns 266,841 shares of the medical device company’s stock valued at $23,296,000 after buying an additional 36,039 shares in the last quarter. Finally, ProShare Advisors LLC raised its stake in shares of Cooper Companies by 7.7% during the 2nd quarter. ProShare Advisors LLC now owns 28,896 shares of the medical device company’s stock worth $2,523,000 after buying an additional 2,078 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2 %

Shares of NASDAQ:COO opened at $95.18 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market cap of $19.00 billion, a price-to-earnings ratio of 48.81, a PEG ratio of 2.36 and a beta of 0.99. The stock’s 50-day moving average price is $96.07 and its two-hundred day moving average price is $99.17. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.87 earnings per share. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Morgan Stanley reduced their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.